logo

Ritter Pharmaceuticals, Inc. (RTTR)



Trade RTTR now with
  Date
  Headline
12/4/2018 8:35:41 AM Ritter Reports Halfway Mark For Enrollment In Pivotal Phase 3 Clinical Trial Of RP-G28
11/9/2018 7:10:01 AM Ritter Pharma Q3 Net Loss $4.6 Mln Or $0.86/Shr Vs Loss $2.0 Mln Or $0.14/Shr Last Year
10/9/2018 8:36:07 AM Ritter Pharma Presents Addl Phase 2b Data Showing Adaptation Of Gut Microbiome
8/14/2018 4:20:02 PM Ritter Pharmaceuticals Q2 Loss/share $0.71 Vs. Loss $1.41 Year Ago
6/27/2018 7:06:42 AM Ritter Pharma Appoints Andrew Ritter As CEO
6/27/2018 7:04:04 AM Ritter Pharmaceuticals Initiates First Pivotal Phase 3 Trial For RP-G28 For Lactose Intolerance
5/29/2018 6:04:48 AM Ritter Pharma Names John Beck As CFO
3/22/2018 11:41:20 AM Ritter Pharmaceuticals Announces 1-for-10 Reverse Stock Split
3/19/2018 6:36:04 AM Ritter Pharma Q4 Loss Per Share $0.11 Vs Loss $0.74 Last Year
3/12/2018 6:04:54 AM Ritter Pharma Reports Microbiome Data From Phase 2b Study Of RP-G28 Promotes Beneficial Adaptation Of The Gut Microbiome